US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF

62.29

-0.3700-0.59%

Volume:18.02K

Turnover:1.12M

Market Cap:722.56M

PE:- -

High:62.43

Open:62.12

Low:62.12

Close:62.66

Loading ...

Overview Company News Filings

Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death

Asieris Signs Supply Deal with US CDC for Free-Living Amoeba Infection Treatment

MT Newswires Live

S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential

Moderna Stock Soars After First US Bird-Flu Death

Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand

Infratil Says CDC Secured Over 230 Megawatts in New Customer Contracts

MT Newswires Live

Infratil’s CDC Secures Significant Growth with New Contracts and Funding

Major supermarkets offer return vouchers to shoppers who use CDC vouchers

Singaporean households can claim S$300 CDC vouchers from Jan 3

Singaporean households can now claim S$300 CDC vouchers, half for use at supermarkets

ASX healthcare 2024 winners and losers, plus what’s next for 2025

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression

Press Release: Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval

Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?

Macron Names State Lender CDC’s Lombard Finance Minister

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Press Release: Carlsquare Advises Boomi on Acquisition of Data Integration Provider Rivery

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

TOMI Environmental Stands Ready to Protect Public Health Amidst H5N1 Bird Flu California State Emergency

Honda teases two 0 Series EV prototypes to be unveiled at CES and hit the global market in 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CDC/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDC\",,,,,undefined,":{"symbol":"CDC","market":"US","secType":"STK","nameCN":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","latestPrice":62.29,"timestamp":1746475200000,"preClose":62.66,"halted":0,"volume":18023,"delay":0,"floatShares":11600000,"shares":11600000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.37,"latestTime":"05-06 07:19:08 EDT","open":62.12,"high":62.4327,"low":62.12,"amount":1123481.386121,"amplitude":0.00499,"askPrice":71.5,"askSize":100,"bidPrice":53.75,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746538200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":62.29,"sharesOutstanding":11600000,"nav":62.613985,"aum":726322400,"dividendRate":0.03323,"bidAskSpread":0.000733,"postHourTrading":{"tag":"盘后","latestPrice":62.14,"preClose":62.29,"latestTime":"16:08 EDT","volume":8,"amount":496.45,"timestamp":1746475681957},"volumeRatio":0.7514279758182197,"impliedVol":0.0857,"impliedVolPercentile":0.7269},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDC\",,,,,undefined,":{"symbol":"CDC","floatShares":11600000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7514279758182197,"shares":11600000,"dividePrice":2.069911,"high":62.4327,"amplitude":0.00499,"preClose":62.66,"low":62.12,"week52Low":57.37,"pbRate":"--","week52High":67.7599,"institutionHeld":0,"latestPrice":62.29,"eps":0,"divideRate":0.03323,"volume":18023,"delay":0,"ttmEps":0,"open":62.12,"prevYearClose":62.58,"prevWeekClose":62.66,"prevMonthClose":62.35,"prevQuarterClose":65.72,"fiveDayClose":61.97,"twentyDayClose":60.18,"sixtyDayClose":64.265},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDC\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2501778257","title":"Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death","url":"https://stock-news.laohu8.com/highlight/detail?id=2501778257","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501778257?lang=en_us&edition=fundamental","pubTime":"2025-01-08 19:52","pubTimestamp":1736337120,"startTime":"0","endTime":"0","summary":"On Monday, the U.S. Centers for Disease Control and Prevention  reported the first human death in the country from the H5N1 virus, also known as bird flu.Despite the death, CDC believes that the risk to the general public remains low due to a lack of evidence of human-to-human transmission. However, the regulatory body remains vigilant and even uses its flu surveillance systems to monitor for H5N1 activity, especially in people exposed to animals. There is still no evidence of human-to-human transmission.As of Jan. 6, the CDC confirmed 66 human cases of H5N1 virus in the country since the beginning of last year. In most of these cases, the patient experienced only mild symptoms like eye redness, with some reports of fever and respiratory symptoms.The agency also remains alert for H5N1 activities outside the country. Over 950 cases of H5N1 flu have been reported to the World Health Organization, half of which have resulted in death.Shares of several vaccine makers, including Moderna MRN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaccine-stocks-jump-cdc-reports-115200423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","SG9999002224.SGD","SG9999003800.SGD","LU1894683348.USD","SG9999002232.USD","LU0058720904.USD","SG9999001176.SGD","NVAX","IE0002270589.USD","LU0868494617.USD","MRNA","IE00B19Z3581.USD","SG9999001176.USD","IE00B19Z3B42.SGD","BK4588","LU0170899867.USD","BK4007","LU1066053197.SGD","LU0225284248.USD","LU1023059063.AUD","LU1057294990.SGD","BK4585","CDC","BK4581","BK4534","BK4551","BK4535","SG9999013999.USD","BK4501","LU0234572021.USD","BK4599","LU0456855351.SGD","BK4139","BNTX","LU0321505439.SGD","LU0985481810.HKD","BK4592","IE00BLSP4452.SGD","BK4533","LU1066051498.USD","LU0306806265.USD","CVAC","PFE","SG9999011175.SGD","BK4568","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","LU0225771236.USD","SGXZ57979304.SGD"],"gpt_icon":1},{"id":"2501796896","title":"Asieris Signs Supply Deal with US CDC for Free-Living Amoeba Infection Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2501796896","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501796896?lang=en_us&edition=fundamental","pubTime":"2025-01-08 12:08","pubTimestamp":1736309294,"startTime":"0","endTime":"0","summary":"Jiangsu Yahong Meditech (SHA:688176) or Asieris Pharmaceuticals signed an investigational drug supply agreement with the US Centers for Disease Control and Prevention for its APL-1202 medication for f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688176","BK0239","CDC"],"gpt_icon":0},{"id":"2501751387","title":"S&P 500 Gains and Losses Today: Moderna Soars on Bird Flu Vaccine Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2501751387","media":"Investopedia","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501751387?lang=en_us&edition=fundamental","pubTime":"2025-01-08 05:52","pubTimestamp":1736286774,"startTime":"0","endTime":"0","summary":"The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.Shares of data analytics software firm Palantir lost ground for the second straight session after Morgan Stanley analysts cited valuation concerns.Moderna shares surged as reports of the country's first bird-flu fatality sparked interest in the biotech firm's experimental H5N1 vaccine.Major U.S. equities indexes lost ground as the latest Purchasing Managers' Index  showed an expansion in the manufacturing sector but revealed an increase in the \"prices paid\" index during December.The indication of pricing pressure in the final month of 2024 could encourage a cautious stance by Federal Reserve policymakers as they weigh the appropriate timing and magnitude of additional interest rate cuts this year.The S&P 500 slipped 1.1%. Underperformance in the technology sector dragged on the Nasdaq, which fell 1.9%, while the Dow ended the session 0.4% lower.Share","market":"sg","thumbnail":"https://www.investopedia.com/thmb/-FG1R_VWVTafa4E_t5waOw_AHU0=/5646x3764/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151784870-7b56f9a9411c42429a1f3aacf3c356e4.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/-FG1R_VWVTafa4E_t5waOw_AHU0=/5646x3764/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2151784870-7b56f9a9411c42429a1f3aacf3c356e4.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/s-and-p-500-gains-and-losses-today-moderna-soars-as-us-sees-first-bird-flu-fatality-8770378","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["BK4534","OEF","IE0004445015.USD","MRNA","CDC","03160","PLTR","LU1814569148.SGD","SPXU","LU2491050071.SGD","SDS","VOO","2NVD.UK","NVIW.SI","OEX","NVDY","SH","LU0724618433.USD","TAN","LU0494093205.USD","UPRO","SG9999014575.USD","BK4548","IVV","ESmain","SPY","HCA","ENPH","NVDD","IE00B19Z8X17.USD","NVD2.UK","3NVD.UK","SNVD.UK","LU2211814178.USD","NVD","NVDU","NVDS.UK","NVD3.UK","NVDX","LU2087625088.SGD","SSO","NVDS","FSLR","NVDA","TM",".SPX","LU0795875086.SGD","LU0345768153.USD"],"gpt_icon":1},{"id":"2501173637","title":"Moderna Stock Soars After First US Bird-Flu Death","url":"https://stock-news.laohu8.com/highlight/detail?id=2501173637","media":"Investopedia","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501173637?lang=en_us&edition=fundamental","pubTime":"2025-01-08 01:35","pubTimestamp":1736271311,"startTime":"0","endTime":"0","summary":"Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S.The biotech company is developing a vaccine for H5N1.Despite Tuesday's gains, Moderna shares are down more than 55% over the past year.Moderna  shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was reported in the U.S.The biotech company is developing a vaccine for H5N1.On Monday, the Centers for Disease Control and Prevention  said that it was \"saddened by Louisiana's report that a person previously hospitalized with severe avian influenza A  illness [had] passed away.\" The agency added that it was \"not unexpected because of the known potential for infection with these viruses to cause severe illness and death.\". As of Monday, there had \"been 66 confirmed human cases of H5N1 bird flu in the United States since 2024 and 67 since 2022,\" the CDC added.Do you have a news tip for Investopedia reporters?","market":"nz","thumbnail":"https://www.investopedia.com/thmb/ccgcLXRxBCEMcpI8VZGfDEoineo=/4318x3239/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2150746943-29953a04619c4fbe959376f97c6b6a10.jpg","type":0,"news_type":0,"thumbnails":["https://www.investopedia.com/thmb/ccgcLXRxBCEMcpI8VZGfDEoineo=/4318x3239/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2150746943-29953a04619c4fbe959376f97c6b6a10.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investopedia.com/moderna-stock-soars-after-first-us-bird-flu-death-8770441","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investopedia_highlight","symbols":["BK4551","BK4532","BK4568","BK4588","BK4533","BK4585","BK4501","BK4139","BK4534","MRNA","BK4548","CDC"],"gpt_icon":1},{"id":"2501784874","title":"Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2501784874","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501784874?lang=en_us&edition=fundamental","pubTime":"2025-01-08 00:26","pubTimestamp":1736267193,"startTime":"0","endTime":"0","summary":"Tuesday saw bumps in Moderna , Novavax , and other vaccine producers as worries about rising COVID-19 and flu infections in the United States drove demand for immunization-oriented businesses to continue growing.Moderna rose 11%; Novavax and others, including Inovio Pharmaceuticals , CureVac , and Arcturus Therapeutics , also traded significantly higher. Manufacturers of the COVID-19 vaccination Comirnaty, Pfizer  and BioNTech , noted more meager increases.GuruFocus has detected 6 Warning Signs with MRNA.Based on last week's U.S. Centers for Disease Control and Prevention  data showing increasing COVID-19 activity in most areas and a concurrent rise in seasonal flu, especially among small children, the rally followed last week's Citing their success in lowering serious disease and hospitalization, the CDC advised Americans to get recommended vaccinations.The organization also underlined how common respiratory syncytial virus  is in young children. With its mREVIA medicine, Moderna has ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaccine-stocks-surge-moderna-jumps-162633280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4583","BK4139","PSQ","BK4548","IE00BLSP4452.SGD","BNTX","INO","BK4501","LU0225771236.USD","BK4532","LU0868494617.USD","LU0058720904.USD","LU1066051498.USD","BK4585","CDC","USAW.SI","QID","MRNA","CVAC","LU1883839398.USD","SG9999013999.USD","NVAX","TQQQ","TSYW.SI","LU0306807586.USD","BK4599","ARCT","LU0122379950.USD","BK4007","BK4588","NVIW.SI","LU0456855351.SGD","LU1894683348.USD","BK4551","LU1894683264.USD","SQQQ","MNQmain","SGXZ57979304.SGD","IE00B19Z3B42.SGD",".IXIC","QLD","NQmain","LU0170899867.USD","PFE","USJW.SI","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","BK4581"],"gpt_icon":1},{"id":"2501429494","title":"Infratil Says CDC Secured Over 230 Megawatts in New Customer Contracts","url":"https://stock-news.laohu8.com/highlight/detail?id=2501429494","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501429494?lang=en_us&edition=fundamental","pubTime":"2025-01-06 09:21","pubTimestamp":1736126488,"startTime":"0","endTime":"0","summary":"Infratil  said that data center CDC, in which it holds a 48.2% stake, has successfully secured over 230 megawatts  of new customer contracts, with more than half of these agreements in the form of reservations, according to a Monday filing with the Australian and New Zealand bourse.CDC expects a \"significant\" portion of these reservations to convert into customer capacity in 2025, the filing said.The data center has 388 MW of built capacity under construction and plans to start additional projects totaling over 200 MW within six months, the company said.The company's Australia and New Zealand shares were each down past 1% in recent Monday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7105","BK7006","CDC","BK7134","XJO.AU","XAO.AU","XKO.AU","IFT.AU"],"gpt_icon":0},{"id":"2501444635","title":"Infratil’s CDC Secures Significant Growth with New Contracts and Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2501444635","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501444635?lang=en_us&edition=fundamental","pubTime":"2025-01-06 04:42","pubTimestamp":1736109733,"startTime":"0","endTime":"0","summary":"Infratil Limited ( ($IFUUF) ) has provided an announcement. Infratil Limited has announced that CDC, a key data center investment, has secured over...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/infratils-cdc-secures-significant-growth-with-new-contracts-and-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/infratils-cdc-secures-significant-growth-with-new-contracts-and-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2500198300","title":"Major supermarkets offer return vouchers to shoppers who use CDC vouchers","url":"https://stock-news.laohu8.com/highlight/detail?id=2500198300","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500198300?lang=en_us&edition=fundamental","pubTime":"2025-01-03 17:00","pubTimestamp":1735894832,"startTime":"0","endTime":"0","summary":"SINGAPORE: Several supermarkets in Singapore are offering return vouchers to encourage customers to spend their Community Development Council  vouchers there.The latest tranche of CDC vouchers - meant to help households manage cost of living challenges - was launched on Friday .Similar to previous rounds, half of the S$300  vouchers can be spent at participating heartland merchantsand hawkers, and the rest at supermarkets.This year, in celebration of SG60, some heartland merchants and hawkers will provide additional discounts or gifts for customers who use CDC vouchers at their stores, while some supermarkets will also have in-house promotions.Following the launch, four supermarket chains - Cold Storage, Giant Singapore, NTUC FairPrice and Prime Supermarket - announced incentives for customers to spend their CDC vouchers.FairPrice Group saidon Friday that it would distribute a S$6 return voucher for every S$60 worth of CDC supermarket vouchers spent in a single transaction at any FairP","market":"us","thumbnail":"https://dam.mediacorp.sg/image/upload/s--MQc7ChJl--/c_crop,h_2268,w_4032,x_0,y_0/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2023/01/03/img_1818.jpg?itok=pIad4tI1","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--MQc7ChJl--/c_crop,h_2268,w_4032,x_0,y_0/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2023/01/03/img_1818.jpg?itok=pIad4tI1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/major-supermarkets-ntuc-fairprice-giant-cold-storage-prime-return-vouchers-use-cdc-4836501","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2500159942","title":"Singaporean households can claim S$300 CDC vouchers from Jan 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2500159942","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500159942?lang=en_us&edition=fundamental","pubTime":"2025-01-03 12:15","pubTimestamp":1735877700,"startTime":"0","endTime":"0","summary":"This latest tranche of CDC vouchers was announced as part of enhancements to the Assurance Package during Budget 2024.","market":"us","thumbnail":"https://dam.mediacorp.sg/image/upload/s--iqUo4CSb--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2023/01/03/IMG_1814.jpg?itok=Ctu4_itI","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--iqUo4CSb--/c_fill,g_auto,h_468,w_830/fl_relative,g_south_east,l_mediacorp:cna:watermark:2021-08:cna,w_0.1/f_auto,q_auto/v1/mediacorp/cna/image/2023/01/03/IMG_1814.jpg?itok=Ctu4_itI"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/claim-cdc-vouchers-s300-jan-3-supermarket-assurance-package-cost-living-4834836","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2500153989","title":"Singaporean households can now claim S$300 CDC vouchers, half for use at supermarkets","url":"https://stock-news.laohu8.com/highlight/detail?id=2500153989","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500153989?lang=en_us&edition=fundamental","pubTime":"2025-01-03 04:42","pubTimestamp":1735850559,"startTime":"0","endTime":"0","summary":"EVERY Singaporean household can now claim S$300 worth of CDC vouchers to help them alleviate daily expenses.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/singapore/singaporean-households-can-now-claim-s300-cdc-vouchers-half-use-supermarkets","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/singapore/singaporean-households-can-now-claim-s300-cdc-vouchers-half-use-supermarkets","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["CDC"],"gpt_icon":0},{"id":"2495577774","title":"ASX healthcare 2024 winners and losers, plus what’s next for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2495577774","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495577774?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:00","pubTimestamp":1735592437,"startTime":"0","endTime":"0","summary":"The S&P/ASX 200 Health Care Index rose 6.98% in 2024 underperforming the benchmark S&P/ASX 200, which was up 8.5%. Morgans’s healthcare analyst Iain Wilkie described 2024 as “pretty patchy” for the ASX healthcare sector. Mesoblast was the top healthcare performer for 2024, up 835% on the back of FDA approval of its therapy for paediatric graft-versus-host disease ","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2024/12/1200jpg-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2024/12/1200jpg-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/asx-healthcare-2024-winners-and-losers-plus-whats-next-for-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["HHS","BK4009","CDC"],"gpt_icon":0},{"id":"2495154057","title":"NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Files Initial Section of U.S. New Drug Application to the FDA for NRX-100 (IV Ketamine) for the Treatment of Suicidal Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2495154057","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495154057?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:03","pubTimestamp":1735563780,"startTime":"0","endTime":"0","summary":"Aiming to be the first FDA-approved medication to treat suicidal depression. Designed to help address the needs of the more than 13 million Americans who seriously consider suicide each year . Completion of NDA filing expected in the first quarter of 2025. Company to participate in 1x1 meetings in San Francisco during the Annual J.P. Morgan Healthcare Conference on January 13-16, 2025, in San Francisco, CA. To schedule meetings, please contact jpm@astrpartners.com. While assembly of the clinical data sections is being completed, FDA has asked the Company to submit the 1800-page manufacturing section  of the NDA to enable immediate review prior to submission of final efficacy data and other sections of the NDA expected in the first quarter of 2025.Intravenous ketamine is widely accepted as a standard of care for acute treatment of suicidal depression, in the absence of an FDA-labeled product; the only treatment currently approved by the FDA is electroconvulsive therapy . According to th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-130300981.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nrx-pharmaceuticals-inc-nasdaq-nrxp-130300981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NQmain","USJW.SI","IE00BKPKM429.USD","NVIW.SI","NDAQ","MNQmain","CDC",".IXIC","IE00B64PRP62.GBP","TSYW.SI","LU2210149790.SGD","BK4112","BK4007","IE00B3QW5Z07.USD","QLD","USAW.SI","NRXPW","NRXP","IE00BGHQF748.EUR","PSQ","LU2210150020.SGD","LU2095319765.USD","QID","SQQQ","BK4585","BK4588","TQQQ"],"gpt_icon":1},{"id":"2495854117","title":"Press Release: Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2495854117","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495854117?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:00","pubTimestamp":1735563600,"startTime":"0","endTime":"0","summary":"Traws Pharma, Inc. Announces Financing up to $72.6 Million from Leading Healthcare Institutional Investors to Advance Tivoxavir Marboxil Development for H5N1 Bird Flu to Approval. Initial tranche of $20 Million extends cash runway into 1H26, subsequent tranche of up to $52.6 Million will provide for runway 3+ years enabling the company to reach both near-term and long-term value inflecting readouts. \"We are appreciative of the support from new and existing institutional investors including Perceptive Advisors, OrbiMed, Alyeska, Torrey Pines and Ikarian Capital. This financing by high quality investors is transformative for Traws and highlights the meaningful potential for Tivoxavir Marboxil,\" said Iain D. Dukes, MA, DPhil, Executive Chairman of Traws Pharma and Venture Partner of OrbiMed.Traws Pharma will host an update call on Tivoxavir Marboxil during the first quarter of 2025 with additional details forthcoming.This announcement is neither an offer to sell, nor a solicitation of an ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","PK","CEN","BK4007","BK4218","ISBC","HCSG","TRAW","BK4181","BK4211","CDC"],"gpt_icon":1},{"id":"2493089333","title":"Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493089333","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493089333?lang=en_us&edition=fundamental","pubTime":"2024-12-24 20:17","pubTimestamp":1735042620,"startTime":"0","endTime":"0","summary":"Hologic, Inc. HOLX recently entered into an agreement with the Centers for Disease Control and Prevention  to develop analyte-specific reagents  — the “active ingredients” of laboratory-developed tests aimed at detecting H5N1 bird flu. The ASRs are being developed on the company’s Panther Fusion system, a fully automated molecular testing platform that allows labs to quickly consolidate and run multiple assays for women's health, infectious disease and SARS-CoV-2  testing.The latest development builds on the company’s existing strong portfolio of diagnostic solutions, including assays used for the detection of COVID-19.Since the announcement on Dec. 18, HOLX shares edged up 0.3%, finishing at $72.50 yesterday. Hologic’s Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay have played a critical role in the global pandemic response, with the company continuing to innovate in this area. In 2023, it received the FDA’s clearance for a test that can detect SARS-CoV-2, influenza A","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rP1EV4y5.bnG6Q.bCrRgNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rP1EV4y5.bnG6Q.bCrRgNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hologic-teams-cdc-combat-h5n1-121700228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0823416689.USD","LU0012050646.USD","IE00B64QTZ34.USD","BK4588","LU1169590202.USD","BK4082","IE00BLDYK493.USD","BK4548","LU2125909247.SGD","LU0205194284.USD","LU1923622614.USD","BK4198","PAHC","PEN","LU1951198990.SGD","BK4585","CDC","LU0205193047.USD","LU1169589451.USD","LU1951200564.SGD","HAE","LU2125909593.SGD","LU0106261612.USD","LU2433249047.HKD","LU1923623000.USD","HOLX","BK4007"],"gpt_icon":0},{"id":"2493797973","title":"Macron Names State Lender CDC’s Lombard Finance Minister","url":"https://stock-news.laohu8.com/highlight/detail?id=2493797973","media":"Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493797973?lang=en_us&edition=fundamental","pubTime":"2024-12-24 03:36","pubTimestamp":1734982596,"startTime":"0","endTime":"0","summary":" -- President Emmanuel Macron appointed Eric Lombard as France’s finance minister, tapping an experienced finance professional as part of a new cabinet that also returned two former prime ministers to government.Lombard, who currently heads the Caisse des Depots Group — a two-century old financial institution that answers to parliament — is tasked with urgently repairing the country’s finances after the collapse of the previous administration in a battle over next year’s budget.The incoming minister will be a key part of French premier Francois Bayrou’s new government that will aim to quickly pass a 2025 budget and survive any no-confidence motions tabled by the opposition.France has been in political turmoil since June, when Macron dissolved the National Assembly and called elections. The ballot returned a lower house split among three feuding blocs: the leftist New Popular Front alliance, Marine Le Pen’s far-right party and centrists that largely support the president.Bayrou said on ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/megDkKhw9la5xSSUlFrE4Q--~B/aD03NjQ7dz0xMjk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/e9dcd8290168875436cbc3c61fc76f73","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/megDkKhw9la5xSSUlFrE4Q--~B/aD03NjQ7dz0xMjk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/e9dcd8290168875436cbc3c61fc76f73"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/macron-names-state-owned-lender-180647220.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ARZGY","IE00BGHQF748.EUR","LU0061475181.USD","BK4135","CDC","IE00B64PRP62.GBP","ARZGF","IE0034235188.USD","BK4585","BK4117","LU1883839398.USD","BK4588","IE00B3QW5Z07.USD","STT"],"gpt_icon":0},{"id":"2493751469","title":"Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu","url":"https://stock-news.laohu8.com/highlight/detail?id=2493751469","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493751469?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:00","pubTimestamp":1734955200,"startTime":"0","endTime":"0","summary":"Investigational agent in development for treatment or prevention of H5N1 Bird Flu. Potent inhibition of drug-resistant and bird flu viruses in vitro. In vivo study in mice, with H5N1 isolated from an infected dairy worker, showed potent protection and suppression of virus replication in lungs. Traws Pharma is expanding its influenza program to address the potential threat of bird flu. \"In laboratory testing, tivoxavir marboxil inhibited multiple isolates of highly pathogenic avian influenza H5N1. We evaluated the effects of drug treatment in mice exposed to human H5N1, where the virus was isolated from a dairy worker exposed to infected cattle,\" said C. David Pauza, PhD, Chief Science Officer for Traws Pharma. \"Oral treatment with tivoxavir marboxil after the virus infection resulted in complete survival and lung virus levels below the limit of quantitation1. This result is highly encouraging for future clinical development of tivoxavir marboxil for treating human H5N1 influenza.\". No ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YVNx2oT9dYISFKmaBZL4mA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fa5b4fbc1407c77b5c22d9507acdc357","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YVNx2oT9dYISFKmaBZL4mA--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/fa5b4fbc1407c77b5c22d9507acdc357"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/traws-pharma-announces-progress-developing-120000871.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/traws-pharma-announces-progress-developing-120000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","CEN","PRGS","LU2065732104.USD","BK4181","BK4218","TRAW","CDC","BK4097","PK"],"gpt_icon":0},{"id":"2492436560","title":"Press Release: Carlsquare Advises Boomi on Acquisition of Data Integration Provider Rivery","url":"https://stock-news.laohu8.com/highlight/detail?id=2492436560","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492436560?lang=en_us&edition=fundamental","pubTime":"2024-12-20 07:34","pubTimestamp":1734651240,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Dec. 19, 2024 /PRNewswire/ -- Carlsquare announced its role as exclusive financial advisor to Boomi, the intelligent integration and automation leader jointly owned by Francisco Partners and TPG, on its acquisition of Rivery, an advanced data integration provider offering cutting-edge Change Data Capture  for real-time, efficient data movement.Founded with a mission to streamline data management, Rivery enables organizations to deploy data pipelines efficiently by utilizing ELT capabilities. With its innovative solutions, Rivery has established itself as a leader in simplifying data management through real-time data integration and advanced CDC technology.The acquisition represents a significant milestone for Boomi as it accelerates its vision to simplify data management, allowing customers to consolidate on fewer vendors and address evolving data management needs in the age of data-driven decision-making and AI.About Boomi: Boomi is the intelligent integration and autom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Press Release: Carlsquare Advises Boomi on Acquisition of Data Integration Provider Rivery","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDC"],"gpt_icon":0},{"id":"2492517951","title":"TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2492517951","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492517951?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:15","pubTimestamp":1734617700,"startTime":"0","endTime":"0","summary":"Fully funded study to evaluate Wegovy and Ozempic patients at risk for increased inflammation associated with sarcopenic muscle deterioration. Collaboration partner to use AI and machine learning to identify targeted patient pool. Potential entry into high growth GLP-1 market valued at nearly $50 billion in 2024 and projected to surpass $100 billion by 2029. \"The GLP-1 drug class has transformed the pharmaceutical landscape in recent years as the prevalence of obesity surges to record numbers. While GLP-1 receptor agonists are highly effective in treating overweight and obesity, rapid and extensive weight loss can bring a range of dangerous complications including sarcopenic loss of muscle mass and bone density,\" said Mitchell Glass, M.D., President and Chief Medical Officer of TNFA. \"Since our lead drug targets excess pro-inflammatory TNF-alpha, a primary cause of sarcopenia, we believe it could provide a much-needed solution for preserving muscle mass in GLP-1-induced weight loss.Cur","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dGXEvBMjGnfkeCix1GKiBw--~B/aD0yMDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fea004175cb22a0ab84784e513396959","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dGXEvBMjGnfkeCix1GKiBw--~B/aD0yMDA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/fea004175cb22a0ab84784e513396959"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tnf-pharmaceuticals-announces-trial-explore-141500678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4113","BK4590","CBD","CDC","GLP","TNFA","ACB","BK4007","BK4557","BK4144"],"gpt_icon":0},{"id":"2492178342","title":"TOMI Environmental Stands Ready to Protect Public Health Amidst H5N1 Bird Flu California State Emergency","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178342","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178342?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:30","pubTimestamp":1734615000,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., Dec. 19, 2024  -- TOMI Environmental Solutions, Inc.  , a global company specializing in disinfection and decontamination solutions, is closely monitoring the recent declaration of a state of emergency in California due to the H5N1 bird flu outbreak. TOMI is dedicated to providing effective disinfection solutions to combat current and future pandemics, including H5N1.Since April 2024, 61 cases of H5N1 bird flu have been reported in the United States, with the Centers for Disease Control and Prevention  confirming the first severe human case. The recent declaration of a state of emergency in California due to the H5N1 bird flu outbreak highlights the urgent need for effective disinfection and sanitation protocols.“We understand the serious threat posed by H5N1 bird flu and other emerging diseases,” said Dr. Halden Shane, CEO of TOMI Environmental Solutions. “We are ready to deploy SteraMist to help protect public health and prevent the spread of H5N1. This outbreak deman","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/aRfdkXiEGXFC3SahBdjXew--~B/aD0zNTI7dz03MjM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/abd33320393bb1faabd0e40bf761bd27","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/aRfdkXiEGXFC3SahBdjXew--~B/aD0zNTI7dz03MjM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/abd33320393bb1faabd0e40bf761bd27"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tomi-environmental-stands-ready-protect-133000952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0034235188.USD","BK4135","STT","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4585","LU1883839398.USD","LU0061475181.USD","IE00B64PRP62.GBP","BK4120","BK4588","CDC","TOMZ"],"gpt_icon":0},{"id":"2492178162","title":"Honda teases two 0 Series EV prototypes to be unveiled at CES and hit the global market in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2492178162","media":"Electrek","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492178162?lang=en_us&edition=fundamental","pubTime":"2024-12-19 08:00","pubTimestamp":1734566400,"startTime":"0","endTime":"0","summary":"Honda announced it will be back at CES this year, unveiling the next phase of its new 0 Series line of EVs. At this year’s event in Las Vegas, Honda intends to unveil two prototype EVs based on the concepts that debuted a year prior. This will be our next look at Honda’s 0 Series progress as it looks to bring these two initial models to market in 2026. ","market":"us","thumbnail":"https://electrek.co/wp-content/uploads/sites/3/2024/12/Honda-0-Series-concepts-CES.jpg?quality=82&strip=all&w=1400","type":0,"news_type":0,"thumbnails":["https://electrek.co/wp-content/uploads/sites/3/2024/12/Honda-0-Series-concepts-CES.jpg?quality=82&strip=all&w=1400"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://electrek.co/2024/12/18/honda-0-series-ev-prototypes-unveilet-ces-hit-global-market-2026/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"electrek_highlight","symbols":["CDC","BK4099","BK4555","BK4585","HMC","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":186,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDC\",params:#limit:5,,,undefined,":[{"date":"2025-04-10","symbol":"CDC","amount":0.22096,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-10","defaultRemindTime":1744291800000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-10","currency":"USD","dateTimestamp":1744257600000,"payDate":"2025-04-11"},{"date":"2025-03-10","symbol":"CDC","amount":0.20589,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-10","defaultRemindTime":1741613400000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-11","payableDate":"2025-03-10","currency":"USD","dateTimestamp":1741579200000,"payDate":"2025-03-11"},{"date":"2025-02-07","symbol":"CDC","amount":0.133071,"announcedDate":"2025-02-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-07","defaultRemindTime":1738938600000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-10","payableDate":"2025-02-07","currency":"USD","dateTimestamp":1738904400000,"payDate":"2025-02-10"},{"date":"2025-01-08","symbol":"CDC","amount":0.007166,"announcedDate":"2025-01-07","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-08","defaultRemindTime":1736346600000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-09","payableDate":"2025-01-08","currency":"USD","dateTimestamp":1736312400000,"payDate":"2025-01-09"},{"date":"2024-12-12","symbol":"CDC","amount":0.414202,"announcedDate":"2024-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-12","defaultRemindTime":1734013800000,"name":"VictoryShares US EQ Income Enhanced Volatility Wtd ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-13","payableDate":"2024-12-12","currency":"USD","dateTimestamp":1733979600000,"payDate":"2024-12-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDC\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-19","recordDate":"2015-05-21","paymentDate":"2015-05-22","value":0.1054201,"currency":"USD"},{"executeDate":"2015-06-16","recordDate":"2015-06-18","paymentDate":"2015-06-19","value":0.1094172,"currency":"USD"},{"executeDate":"2015-07-21","recordDate":"2015-07-23","paymentDate":"2015-07-24","value":0.0106339,"currency":"USD"},{"executeDate":"2015-08-18","recordDate":"2015-08-20","paymentDate":"2015-08-21","value":0.1070379,"currency":"USD"},{"executeDate":"2015-09-22","recordDate":"2015-09-24","paymentDate":"2015-09-25","value":0.167621,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDC\",market:\"US\",delay:false,,,undefined,":{}}}